Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

USA - NYSE:BX - US09260D1072 - Common Stock

178.08 USD
-6.83 (-3.69%)
Last: 9/24/2025, 8:04:01 PM
178.49 USD
+0.41 (+0.23%)
After Hours: 9/24/2025, 8:04:01 PM
Fundamental Rating

5

Taking everything into account, BX scores 5 out of 10 in our fundamental rating. BX was compared to 236 industry peers in the Capital Markets industry. BX has an excellent profitability rating, but there are concerns on its financial health. BX is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BX had positive earnings in the past year.
In the past year BX had a positive cash flow from operations.
In the past 5 years BX has always been profitable.
BX had a positive operating cash flow in each of the past 5 years.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

BX's Return On Assets of 6.31% is fine compared to the rest of the industry. BX outperforms 77.97% of its industry peers.
BX's Return On Equity of 34.29% is amongst the best of the industry. BX outperforms 96.61% of its industry peers.
Looking at the Return On Invested Capital, with a value of 17.66%, BX belongs to the top of the industry, outperforming 92.80% of the companies in the same industry.
BX had an Average Return On Invested Capital over the past 3 years of 12.81%. This is significantly above the industry average of 7.59%.
The last Return On Invested Capital (17.66%) for BX is above the 3 year average (12.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.31%
ROE 34.29%
ROIC 17.66%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

BX has a Profit Margin (20.83%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of BX has declined.
BX has a better Operating Margin (50.95%) than 85.59% of its industry peers.
BX's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 50.95%
PM (TTM) 20.83%
GM N/A
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, BX has more shares outstanding
BX has more shares outstanding than it did 5 years ago.
BX has a better debt/assets ratio than last year.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

BX has an Altman-Z score of 4.28. This indicates that BX is financially healthy and has little risk of bankruptcy at the moment.
BX has a Altman-Z score of 4.28. This is amongst the best in the industry. BX outperforms 82.63% of its industry peers.
BX has a debt to FCF ratio of 3.66. This is a good value and a sign of high solvency as BX would need 3.66 years to pay back of all of its debts.
BX has a better Debt to FCF ratio (3.66) than 75.85% of its industry peers.
A Debt/Equity ratio of 1.44 is on the high side and indicates that BX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.44, BX is doing worse than 69.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 3.66
Altman-Z 4.28
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 0.70 indicates that BX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.70, BX is doing worse than 66.53% of the companies in the same industry.
BX has a Quick Ratio of 0.70. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
BX has a worse Quick ratio (0.70) than 66.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.31% over the past year.
BX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.97% yearly.
BX shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.33%.
BX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.51% yearly.
EPS 1Y (TTM)25.31%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%26.04%
Revenue 1Y (TTM)33.33%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%22.18%

3.2 Future

The Earnings Per Share is expected to grow by 12.53% on average over the next years. This is quite good.
BX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.92% yearly.
EPS Next Y12.04%
EPS Next 2Y20.42%
EPS Next 3Y21.84%
EPS Next 5Y12.53%
Revenue Next Year9.27%
Revenue Next 2Y18%
Revenue Next 3Y19.89%
Revenue Next 5Y15.92%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.62, which means the current valuation is very expensive for BX.
74.58% of the companies in the same industry are cheaper than BX, based on the Price/Earnings ratio.
BX's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.29.
A Price/Forward Earnings ratio of 26.47 indicates a quite expensive valuation of BX.
BX's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BX is more expensive than 68.64% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.80. BX is around the same levels.
Industry RankSector Rank
PE 35.62
Fwd PE 26.47
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BX is cheaper than 64.41% of the companies in the same industry.
BX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 64.31
EV/EBITDA 32.46
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of BX may justify a higher PE ratio.
A more expensive valuation may be justified as BX's earnings are expected to grow with 21.84% in the coming years.
PEG (NY)2.96
PEG (5Y)2.38
EPS Next 2Y20.42%
EPS Next 3Y21.84%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.26%, BX has a reasonable but not impressive dividend return.
BX's Dividend Yield is comparable with the industry average which is at 8.21.
BX's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

The dividend of BX is nicely growing with an annual growth rate of 11.16%!
BX has paid a dividend for at least 10 years, which is a reliable track record.
BX has decreased its dividend recently.
Dividend Growth(5Y)11.16%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

BX pays out 182.75% of its income as dividend. This is not a sustainable payout ratio.
The dividend of BX is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP182.75%
EPS Next 2Y20.42%
EPS Next 3Y21.84%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

BLACKSTONE INC

NYSE:BX (9/24/2025, 8:04:01 PM)

After market: 178.49 +0.41 (+0.23%)

178.08

-6.83 (-3.69%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-16 2025-10-16/amc
Inst Owners70.37%
Inst Owner Change12.98%
Ins Owners0.8%
Ins Owner Change5.08%
Market Cap210.97B
Analysts76.77
Price Target186.45 (4.7%)
Short Float %1.53%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend6.1
Dividend Growth(5Y)11.16%
DP182.75%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-04 2025-08-04 (1.03)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.84%
Min EPS beat(2)0.65%
Max EPS beat(2)7.03%
EPS beat(4)4
Avg EPS beat(4)6.66%
Min EPS beat(4)0.65%
Max EPS beat(4)12.43%
EPS beat(8)5
Avg EPS beat(8)2.96%
EPS beat(12)7
Avg EPS beat(12)2.84%
EPS beat(16)11
Avg EPS beat(16)8.35%
Revenue beat(2)1
Avg Revenue beat(2)3.38%
Min Revenue beat(2)-0.22%
Max Revenue beat(2)6.98%
Revenue beat(4)2
Avg Revenue beat(4)2.44%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)6.98%
Revenue beat(8)2
Avg Revenue beat(8)-1.46%
Revenue beat(12)2
Avg Revenue beat(12)-13.7%
Revenue beat(16)5
Avg Revenue beat(16)7.59%
PT rev (1m)1.01%
PT rev (3m)20.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.51%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)4.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.79%
Valuation
Industry RankSector Rank
PE 35.62
Fwd PE 26.47
P/S 15.35
P/FCF 64.31
P/OCF 62.4
P/B 25.26
P/tB 33.41
EV/EBITDA 32.46
EPS(TTM)5
EY2.81%
EPS(NY)6.73
Fwd EY3.78%
FCF(TTM)2.77
FCFY1.55%
OCF(TTM)2.85
OCFY1.6%
SpS11.6
BVpS7.05
TBVpS5.33
PEG (NY)2.96
PEG (5Y)2.38
Profitability
Industry RankSector Rank
ROA 6.31%
ROE 34.29%
ROCE 21.17%
ROIC 17.66%
ROICexc 19.13%
ROICexgc 20.63%
OM 50.95%
PM (TTM) 20.83%
GM N/A
FCFM 23.86%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
ROICexc(3y)14.24%
ROICexc(5y)19.2%
ROICexgc(3y)15.53%
ROICexgc(5y)21.12%
ROCE(3y)15.37%
ROCE(5y)21.01%
ROICexcg growth 3Y-21.19%
ROICexcg growth 5Y9.44%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y9.86%
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 3.66
Debt/EBITDA 1.71
Cap/Depr 280.1%
Cap/Sales 0.73%
Interest Coverage 14.47
Cash Conversion 48.02%
Profit Quality 114.54%
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z 4.28
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)360.42%
Cap/Depr(5y)264.86%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.63%
Profit Quality(3y)249.28%
Profit Quality(5y)197.86%
High Growth Momentum
Growth
EPS 1Y (TTM)25.31%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%26.04%
EPS Next Y12.04%
EPS Next 2Y20.42%
EPS Next 3Y21.84%
EPS Next 5Y12.53%
Revenue 1Y (TTM)33.33%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%22.18%
Revenue Next Year9.27%
Revenue Next 2Y18%
Revenue Next 3Y19.89%
Revenue Next 5Y15.92%
EBIT growth 1Y39.89%
EBIT growth 3Y-19.82%
EBIT growth 5Y13.91%
EBIT Next Year5.24%
EBIT Next 3Y19.12%
EBIT Next 5Y6.22%
FCF growth 1Y-6.6%
FCF growth 3Y-4.46%
FCF growth 5Y12.44%
OCF growth 1Y-10.47%
OCF growth 3Y-4.41%
OCF growth 5Y12.14%